Search Results for:
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
BBVA funds IBEC research into more efficient cancer drug delivery systems
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.
ICREA research professor Samuel Sánchez’s Smart Nano-Bio-Devices group will receive the support for three years to develop their project ‘MEDIROBOTS: Precision nanobotomy against tumors’.
The project will develop biocompatible robots driven by enzymes with applications as drug release systems whose progress in vitro and in vivo can be traced using advanced molecular imaging techniques such as super-resolution microscopy.
Last week there was a lot of press coverage of the La Caixa PhD fellowships ceremony, which took place at the Caixaforum on 3rd July.
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.